FDA Warns GLP-1s May Increase Risk of Sudden Blindness
7 113An anonymous reader quotes a report from NBC News: The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The condition, called nonarteritic anterior ischemic optic neuropathy, or NAION, affects the optic nerve, which carries signals from the eye to the brain. When blood flow to the nerve is reduced or blocked, it can cause sudden vision loss. The condition is permanent with no known treatment. The FDA said "there is a potential increased risk of rare NAION" in people taking GLP-1 drugs. The agency's requirement applies to all GLP-1s, including Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound, as well as several older GLP-1 diabetes medications. [...] Previous research has found that GLP-1 use may increase the risk of NAION, and Lilly has said it was aware of studies on the potential link.
The FDA said it began looking into a possible link after a 2024 study published in JAMA Ophthalmology that found diabetes patients prescribed semaglutide were four times as likely to develop NAION as those not prescribed the drug. The agency said it reviewed reports of side effects submitted to its adverse event monitoring system and analyzed data from multiple clinical trials. Cases of NAION have been reported for all currently marketed GLP-1 drugs, the FDA found. However, FDA scientists were not able to identify a mechanism for how the drugs could increase the risk of the eye condition. Risk factors for NAION can overlap with conditions seen in people taking GLP-1 drugs, including Type 2 diabetes, obesity, sleep apnea and hypertension. "Patients and caregivers should be aware of a potential increased risk of NAION, a rare condition that can result in acute, painless, decreased vision in one eye, including permanent vision loss," with GLP-1 use, the FDA said in the release.
7 comments
Re:Overprescribed (Score: 5, Insightful)
by lawnboy5-O ( 772026 ) on Monday November 09, 2026 @11:03PM (#66417878)
Processed, synthetic foods, and excess sugar, everywhere.
Re:Overprescribed (Score: 5, Informative)
by darkain ( 749283 ) on Tuesday November 10, 2026 @12:23AM (#66417942)
sugar... erm... high fructose corn syrup
Re:Overprescribed (Score: 5, Insightful)
by stabiesoft ( 733417 ) on Tuesday November 10, 2026 @10:12AM (#66418496)
Sugar definitely plays a role, milk choc has way more sugar than dark. But more than sugar is in play to make it addictive. Someone else pointed out chips, and chips I think is more a salt component. But they all share one thing, the perfect combo of salt/sugar/fat to make it so you want more and more and more. Imagine french fries without salt.
Re:Overprescribed (Score: 5, Interesting)
by wickerprints ( 1094741 ) on Monday November 09, 2026 @11:41PM (#66417900)
While I agree that some people are being prescribed GLP-1s that probably should not be (in the sense that they could achieve similar efficacy through non-pharmaceutical interventions such as diet/exercise), I think for a significant majority of recipients, the metabolic effects of this class of drugs is profound and their benefit far outweighs the risk. Of course, we see clinically significant reductions not only in HbA1c and stronger blood glucose control for T2DM patients as well as prediabetics--as these are the originally intended drug targets--but we also see concomitant reductions in cardiovascular risk, significant reductions in obesity, improved activities of daily living, and an interesting inhibitory effect on non-appetite related cravings (e.g., alcohol, tobacco, and drug use) that was not originally foreseen.
To say that these drugs are too risky and overprescribed based on rare but serious side effects is to dismiss huge benefits for a population of patients whose comorbidities were uncontrolled and essentially had one foot in the grave.
Again, I want to emphasize that GLP-1s are not for everyone, not even for everyone with obesity or T2DM. They have profound effects on the metabolism. We knew this ever since exenatide was developed over a decade ago. That's why they are prescription only. You need to have a doctor evaluate your use on a regular basis. People need to understand that we are all unique in our response to drugs, and that the "average" person doesn't exist. That's why we do clinical trials and postmarketing surveillance--which is also how we caught this particular risk.
Nobody (except anti-science assholes with an agenda) argues against allowing chemotherapy for late stage cancer patients even though they are cytotoxic. You weigh the risk against the benefit. If chemotherapy means one might get 6 months more life, even if it's not pain-free, that's up to the patient to decide. To paint it with a broad brush and argue for denying anyone such treatment because a small fraction of patients won't respond or will experience serious side effects, is barbaric and insane. Yet people hear about some rare but serious side effect in a drug with literal life-saving potential, and demand it be withdrawn from market. That's equally insane.
Yes, there are people who are getting access to this class of drugs who probably don't need it. This phenomenon is not unique to GLP-1s--it's just particularly noticeable in this case because of our society's emphasis on physical appearance. But to suggest that the incidence of obesity was lower in previous generations as some justification for restricting access is wild. It offers no solution for the social, cultural, and economic reasons for the rise in obesity in the first place, so it rings hollow to say GLP-1s are overprescribed while staying silent about the predatory practices of the food industry and how they manipulate the consumption habits of people; the dismantling of physical and dietary education programs in schools; the lack of funding and political resistance to providing healthy school meals; the existence of "food deserts" and proliferation of fast food in economically depressed areas; etc. Medical professionals have been watching this trend with horror and have been repeatedly telling everyone to diet and exercise for the past 50+ years, to no avail. It's not like they haven't tried. The insinuation that the vast majority of obese people are obese by choice and/or lack of sufficient self-control, is an old, old trope that serves no one and needs to die. It doesn't make any sense in a society that is so fixated on superficial physical appearance that people are actively shunned for being overweight.
Re:Overprescribed (Score: 5, Interesting)
by sg_oneill ( 159032 ) on Tuesday November 10, 2026 @12:04AM (#66417928)
So I was skeptical on this, as I certainly remember obese people when I was younger, and decided to do a dig on the stats. Turns out , in a rhetorically exaggerated way you are right.
Overweightness rose roughly from 50% of the population to 70% of the population in the US from 1990 to now. From 35% to 60% in the UK (Though it hasn't risen there in a decade) , and 35% to 62% in Australia, with the same plateau seen in australian data. Japan from 17% to 21%. South Korea from 17% to 37%. And so on.
The conclusions seem complex. The fastest growths seem to be in wealthy western countries, the wealthy asian countries have definitely seen growth but are still significantly lower. I can only conclude there that while people are still over-eating in wealthier asian countries, the diets are healthier and/or people are working out more. There is extremely high obesity in Samoa and pacific islander countries, but these are not recent phenomena and may be keyed to genetic adaptions in fishing people for whom having a bit of extra weight might confer some advantages, evolutionary speaking. I've long suspected human fattiness is a misfiring evolutionary measure to store nutrients in fat for the winter. In the Samoan case, that might not be misfiring at all.
Ah.... ADHD rant. Let me get back on track....
Overweightness is huge burden on the health system, and issues of food security and lifestyle might be making it increasingly harder for people to keep their weight down while simultaneously being bombarded with various perverse incentives to eat absolute trash. If someone in a poor neighborhood can only afford to feed his family nasty mcdonalds crap, then they are gonna eat that instead of a good healthy home cooked meal with an assortment of vegetables and non-preserved meats.
In this regard I think widespread GLP-1 is a good thing that folks are are using GLP-1s to get that weight down. So far other than these rare side effects, they are largely free of downsides except expense, are correlated with improved cardio health, reduction in sleep apnea (which might make a measurable dent in dementia cases), respiratory health, and all around fitness. And most importantly can deeply reduce the caseload of Type 2 Diabetes. In other words, if we can get the prices down, this will likely take a huge chunk out of the costs of maintaining an ageing populations impact on the health spending of society. And that benefits everyone.
Re:Overprescribed (Score: 5, Informative)
by sg_oneill ( 159032 ) on Tuesday November 10, 2026 @01:44AM (#66418002)
I will add one caveat regarding weight and elderly health.
While it IS true that nutrient restriction is correlated with longer lifespans (although you basically need to practically live a full starved life , cradle to grave, for this to be significant) , and of course in many metrics being a healthy weight is absolutely more healthier, in late life there is actually some value in being *slightly* overweight, because thin elders are more prone to hip injuries and other broken bones from falls , and a hip injury can be a death sentence if your old enough. Folks just .... don't recover well... So in geriatric cases having a bit of weight can actually be good for you. Not obese, just a little chonky padding to help cuishon falls. Beyond that, a bit of fat can actually be protective beyond about 70-75. But crucially, we dont actually know why. So one would presume that the key here is to stay thin until 70, at which point, it is useful then to put a few happy kilos on.
There was a sample size of around 9000 participants, roughly 50/50 m/f
Reference:
Flicker, L., McCaul, K.A., Hankey, G.J., Jamrozik, K., Brown, W.J., Byles, J.E. and Almeida, O.P. (2010), Body Mass Index and Survival in Men and Women Aged 70 to 75. Journal of the American Geriatrics Society, 58: 234-241.
https://agsjournals.onlinelibr... [wiley.com]
Sudden blindness is also caused by... (Score: 5, Interesting)
by thegarbz ( 1787294 ) on Tuesday November 10, 2026 @05:07AM (#66418188)
Type 2 diabetes. On balance diabetics probably should stay on GPL-1 if they need it to manage weight.
That said it's insane to hear how these are being fed like candy to people in America and Australia. The drug is insanely difficult to get over here. A limited number of doctors have permission to prescribe it, and often only do so to manage overweight diabetics, not just generally fat people.